Search

Your search keyword '"Gross WL"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Gross WL" Remove constraint Author: "Gross WL" Publisher bmj Remove constraint Publisher: bmj
37 results on '"Gross WL"'

Search Results

2. Genetics of toll like receptor 9 in ANCA associated vasculitides.

3. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.

4. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.

5. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.

6. Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's).

10. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

14. Severe impaired respiratory ciliary function in Wegener granulomatosis.

15. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

16. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.

17. The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping.

18. The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis.

19. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

20. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis.

22. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions.

23. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.

24. Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus.

25. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?

29. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.

31. Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS).

32. Urinary bladder cancer in Wegener's granulomatosis: is it more than cyclophosphamide?

34. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.

35. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Catalog

Books, media, physical & digital resources